Capstone Capital Management Ltd

Position in WVE — Wave Life Sciences, Inc.

CIK 2069260 HONG KONG, K3

Position in WVE

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$308,598

-$735,612 QoQ

Shares Held

53,115

-63.1% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#119

of 237 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capstone Capital Management Ltd holds $1,120,063 across 3 Biotechnology names. WVE ranks #3 (27.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NKTR	Nektar Therapeutics	7,066	$493,277
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,057	$318,188
3	WVE	Wave Life Sciences, Inc. This page	53,115	$308,598

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$308,598	53,115	-63.1%	Shares	Sole	2026-07-20
2026-03-31	$1,044,210	144,029	—	Shares	Sole	2026-04-30
No filing history on record for this holder in this stock.